<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Mirum Pharmaceuticals, Inc. (MIRM) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/mirm/</link>
<description>Every dated entry in the public record on Mirum Pharmaceuticals, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/mirm/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Wed, 28 Oct 2026 00:00:00 +0000</lastBuildDate>
<item><title>Mirum Pharmaceuticals, Inc. filed 8-K: other events</title><link>https://greeksoup.ai/stocks/us/mirm/filings/</link><guid isPermaLink="false">us:MIRM:filing:2026-10-26:954eda99df</guid><pubDate>Mon, 26 Oct 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000175942526000054/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: short interest 6,663,045 shares at the 15 October 2026 settlement, 7.30 days to cover</title><link>https://greeksoup.ai/stocks/us/mirm/short-interest/</link><guid isPermaLink="false">us:MIRM:short-interest:2026-10-15:fc710485a2</guid><pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc. filed 8-K: other events</title><link>https://greeksoup.ai/stocks/us/mirm/filings/</link><guid isPermaLink="false">us:MIRM:filing:2026-10-13:7de8e6ebcf</guid><pubDate>Tue, 13 Oct 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000175942526000051/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: short interest 6,985,385 shares at the 30 September 2026 settlement, 7.67 days to cover</title><link>https://greeksoup.ai/stocks/us/mirm/short-interest/</link><guid isPermaLink="false">us:MIRM:short-interest:2026-09-30:03e0f05775</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc. filed 8-K: other events</title><link>https://greeksoup.ai/stocks/us/mirm/filings/</link><guid isPermaLink="false">us:MIRM:filing:2026-09-28:d2783505f3</guid><pubDate>Mon, 28 Sep 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000175942526000049/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Form 144, ERIC BJERKHOLT plans to sell 9,943 shares worth $978,093 around 14 September 2026</title><link>https://greeksoup.ai/stocks/us/mirm/planned-sales/</link><guid isPermaLink="false">us:MIRM:planned-sale:2026-09-15:06a256aa69</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000119735026000011/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Bjerkholt Eric (CHIEF FINANCIAL OFFICER) sold 9,943 shares at $98.37 on 14 September 2026, $978,093</title><link>https://greeksoup.ai/stocks/us/mirm/insiders/</link><guid isPermaLink="false">us:MIRM:insider:2026-09-15:4889a34b4e</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000119735026000010/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: short interest 6,281,413 shares at the 15 September 2026 settlement, 11.99 days to cover</title><link>https://greeksoup.ai/stocks/us/mirm/short-interest/</link><guid isPermaLink="false">us:MIRM:short-interest:2026-09-15:be34bd1e56</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc. filed 8-K: officer or director change</title><link>https://greeksoup.ai/stocks/us/mirm/filings/</link><guid isPermaLink="false">us:MIRM:filing:2026-09-08:c810d90abb</guid><pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000175942526000047/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Howe Jolanda (SVP, GLOBAL CONTROLLER) sold 658 shares (under a trading plan set in advance) at $100.00 on 2 September 2026, $65,800</title><link>https://greeksoup.ai/stocks/us/mirm/insiders/</link><guid isPermaLink="false">us:MIRM:insider:2026-09-03:b2408fb5b8</guid><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000197420026000013/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Peetz Christopher (CHIEF EXECUTIVE OFFICER) sold 8,312 shares (under a trading plan set in advance) at $98.08 on 1 September 2026, $815,241</title><link>https://greeksoup.ai/stocks/us/mirm/insiders/</link><guid isPermaLink="false">us:MIRM:insider:2026-09-03:087e06d90d</guid><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000161474026000013/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Peetz Christopher (CHIEF EXECUTIVE OFFICER) sold 21,688 shares (under a trading plan set in advance) at $98.91 on 1 September 2026, $2.1 million</title><link>https://greeksoup.ai/stocks/us/mirm/insiders/</link><guid isPermaLink="false">us:MIRM:insider:2026-09-03:fed4d341a1</guid><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000161474026000013/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Form 144, JOLANDA MARIE HOWE plans to sell 658 shares worth $65,800 around 2 September 2026</title><link>https://greeksoup.ai/stocks/us/mirm/planned-sales/</link><guid isPermaLink="false">us:MIRM:planned-sale:2026-09-02:81ed4903b0</guid><pubDate>Wed, 02 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000195004726008986/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Form 144, CHRISTOPHER PEETZ plans to sell 30,000 shares worth $3.0 million around 1 September 2026</title><link>https://greeksoup.ai/stocks/us/mirm/planned-sales/</link><guid isPermaLink="false">us:MIRM:planned-sale:2026-09-01:75df480ccf</guid><pubDate>Tue, 01 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000195004726008900/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: short interest 6,171,979 shares at the 31 August 2026 settlement, 13.21 days to cover</title><link>https://greeksoup.ai/stocks/us/mirm/short-interest/</link><guid isPermaLink="false">us:MIRM:short-interest:2026-08-31:454adb760d</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Howe Jolanda (SVP, GLOBAL CONTROLLER) sold 40,000 shares at $100.00 on 18 August 2026, $4.0 million</title><link>https://greeksoup.ai/stocks/us/mirm/insiders/</link><guid isPermaLink="false">us:MIRM:insider:2026-08-19:27b8162b6e</guid><pubDate>Wed, 19 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000197420026000012/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Form 144, JOLANDA MARIE HOWE plans to sell 40,000 shares worth $4.0 million around 18 August 2026</title><link>https://greeksoup.ai/stocks/us/mirm/planned-sales/</link><guid isPermaLink="false">us:MIRM:planned-sale:2026-08-18:8d81936cc7</guid><pubDate>Tue, 18 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000195004726008352/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: short interest 6,489,383 shares at the 14 August 2026 settlement, 7.27 days to cover</title><link>https://greeksoup.ai/stocks/us/mirm/short-interest/</link><guid isPermaLink="false">us:MIRM:short-interest:2026-08-14:ecf010b940</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Schedule 13G/A filed by JANUS HENDERSON GROUP Ltd., 9.7% of the class</title><link>https://greeksoup.ai/stocks/us/mirm/holders/</link><guid isPermaLink="false">us:MIRM:schedule-13:2026-08-13:a1f7909c42</guid><pubDate>Thu, 13 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000127417326000210/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Bjerkholt Eric (CHIEF FINANCIAL OFFICER) sold 6,001 shares (under a trading plan set in advance) at $99.90 on 11 August 2026, $599,510</title><link>https://greeksoup.ai/stocks/us/mirm/insiders/</link><guid isPermaLink="false">us:MIRM:insider:2026-08-12:c4424cea93</guid><pubDate>Wed, 12 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000119735026000009/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Form 144, ERIC BJERKHOLT plans to sell 6,001 shares worth $599,510 around 11 August 2026</title><link>https://greeksoup.ai/stocks/us/mirm/planned-sales/</link><guid isPermaLink="false">us:MIRM:planned-sale:2026-08-11:96e25553a5</guid><pubDate>Tue, 11 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000195004726007935/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Peetz Christopher (CHIEF EXECUTIVE OFFICER) sold 11,683 shares (under a trading plan set in advance) at $98.51 on 10 August 2026, $1.2 million</title><link>https://greeksoup.ai/stocks/us/mirm/insiders/</link><guid isPermaLink="false">us:MIRM:insider:2026-08-11:f55292cdd8</guid><pubDate>Tue, 11 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000161474026000012/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Peetz Christopher (CHIEF EXECUTIVE OFFICER) sold 6,017 shares (under a trading plan set in advance) at $99.25 on 10 August 2026, $597,187</title><link>https://greeksoup.ai/stocks/us/mirm/insiders/</link><guid isPermaLink="false">us:MIRM:insider:2026-08-11:18fdeeb1bc</guid><pubDate>Tue, 11 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000161474026000012/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Peetz Christopher (CHIEF EXECUTIVE OFFICER) sold 2,300 shares (under a trading plan set in advance) at $100.14 on 10 August 2026, $230,322</title><link>https://greeksoup.ai/stocks/us/mirm/insiders/</link><guid isPermaLink="false">us:MIRM:insider:2026-08-11:1045f7d6f5</guid><pubDate>Tue, 11 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000161474026000012/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Form 144, CHRISTOPHER PEETZ plans to sell 20,000 shares worth $2.0 million around 10 August 2026</title><link>https://greeksoup.ai/stocks/us/mirm/planned-sales/</link><guid isPermaLink="false">us:MIRM:planned-sale:2026-08-10:4970bd9f7b</guid><pubDate>Mon, 10 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000195004726007862/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Schedule 13G filed by FMR LLC, 6.2% of the class</title><link>https://greeksoup.ai/stocks/us/mirm/holders/</link><guid isPermaLink="false">us:MIRM:schedule-13:2026-08-06:e7cce7ac5b</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000031506626002080/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc. Q2 FY2026 results: revenue $176 million, net income -$67 million</title><link>https://greeksoup.ai/stocks/us/mirm/results/fy2026-q2/</link><guid isPermaLink="false">us:MIRM:result:2026-08-05:6bab5a8cb0</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001759425&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/results/fy2026-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc. filed 10-Q: 10-q</title><link>https://greeksoup.ai/stocks/us/mirm/filings/</link><guid isPermaLink="false">us:MIRM:filing:2026-08-05:5dd5bc8001</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000175942526000045/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc. filed 8-K: results of operations</title><link>https://greeksoup.ai/stocks/us/mirm/filings/</link><guid isPermaLink="false">us:MIRM:filing:2026-08-05:7bbd8cd5ab</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000175942526000044/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Howe Jolanda (SVP, GLOBAL CONTROLLER) sold 1,840 shares (under a trading plan set in advance) at $105.29 on 3 August 2026, $193,734</title><link>https://greeksoup.ai/stocks/us/mirm/insiders/</link><guid isPermaLink="false">us:MIRM:insider:2026-08-05:13c012f7a1</guid><pubDate>Wed, 05 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000197420026000011/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: Form 144, JOLANDA MARIE HOWE plans to sell 1,840 shares worth $193,734 around 3 August 2026</title><link>https://greeksoup.ai/stocks/us/mirm/planned-sales/</link><guid isPermaLink="false">us:MIRM:planned-sale:2026-08-03:dce042f70f</guid><pubDate>Mon, 03 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1759425/000195004726007486/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Mirum Pharmaceuticals, Inc.: short interest 6,823,706 shares at the 31 July 2026 settlement, 12.05 days to cover</title><link>https://greeksoup.ai/stocks/us/mirm/short-interest/</link><guid isPermaLink="false">us:MIRM:short-interest:2026-07-31:6b3c95a409</guid><pubDate>Fri, 31 Jul 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mirm/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
